How to identify the right KOLs for pharma marketing
Pharma companies know their drugs best. But getting your drugs to market and gaining credibility can be a difficult proc
Digital therapeutics: Driving the future of care delivery
You are in a doctor’s waiting room. A few people who appear to be in distress are sitting on the chairs that line
DTx in mental health: Building a happier and healthier tomorrow
The COVID-19 pandemic, as well as the ensuing economic recession, have had a significant impact on many people’s m
Why healthcare marketers should leverage precision marketing in the new normal
Healthcare marketing has been recently experiencing an increasing rise in consumerism. These days, patients have access
Using smart technology to revolutionize eldercare
COVID-19 has upended almost every segment of the global healthcare industry, but nowhere are the tectonic shifts more vi
Leveraging healthcare market assessment to navigate the new normal
In the dynamic healthcare industry, navigating rapidly changing market situations necessitates an ongoing comprehensive
Robotic Surgery: A hi-tech path to the future of healthcare
The future of robotic surgery in healthcare has finally begun to take shape. Despite having existed for over 20 years, t
AI in life sciences R&D: The startup landscape
The rising costs of drug discovery and development and shorter product lifecycles, coupled with greater risks, are affec
Interview: Emerging trends in decentralized clinical trials post COVID-19
In our recent interview with Dr. Jitesh Bhatt, Vice President of Clinical Product at Wellthy Therapeutics, we explore ho
How Clinical Trials Have Evolved Post COVID-19
Based on inputs by Dr. Jitesh Bhatt, VP, Clinical Product, Wellthy Therapeutics. The race to produce new drugs and vacci
